rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Yuling Luo

Chief Executive Officer

Company insider

Files Form 4 as: Chief Executive Officer, Alamar Biosciences.

In numbers

Trades disclosed
58
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
16 Apr 2026
Last trade
20 Apr 2026
Last filed
20 Apr 2026

Companies traded

Where they are an officer
ALMR Alamar BiosciencesDirector, Officer · Life-science tools · last 20 Apr 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
20 Apr 2026filed 20 Apr 2026ALMR Alamar BiosciencesLife-science toolsSEC FORM 4 Code C—1,386,746filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar Biosciencesoption or derivative · Life-science toolsSEC FORM 4 Code C—1,020,742 at $0.00filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar Biosciencesoption or derivative · Life-science toolsSEC FORM 4 Code C—366,004 at $0.00filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar Biosciencesoption or derivative · Life-science toolsSEC FORM 4 Code C—880,802 at $0.00filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar Biosciencesoption or derivative · Life-science toolsSEC FORM 4 Code C—1,224,152 at $0.00filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar Biosciencesoption or derivative · Life-science toolsSEC FORM 4 Code J—266,311 at $0.00filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar Biosciencesoption or derivative · Life-science toolsSEC FORM 4 Code J—266,311 at $0.00filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar Biosciencesoption or derivative · Life-science toolsSEC FORM 4 Code J—25,310 at $0.00filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar Biosciencesoption or derivative · Life-science toolsSEC FORM 4 Code J—25,310 at $0.00filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar Biosciencesoption or derivative · Life-science toolsSEC FORM 4 Code J—23,986 at $0.00filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar Biosciencesoption or derivative · Life-science toolsSEC FORM 4 Code J—23,986 at $0.00filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar BiosciencesLife-science toolsSEC FORM 4 Code C—364,268filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar Biosciencesoption or derivative · Life-science toolsSEC FORM 4 Code J—20,023 at $0.00filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar Biosciencesoption or derivative · Life-science toolsSEC FORM 4 Code J—20,023 at $0.00filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar Biosciencesoption or derivative · Life-science toolsSEC FORM 4 Code J—27,700 at $0.00filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar Biosciencesoption or derivative · Life-science toolsSEC FORM 4 Code J—27,700 at $0.00filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar Biosciencesoption or derivative · Life-science toolsSEC FORM 4 Code J—1,033,912 at $0.00filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar Biosciencesoption or derivative · Life-science toolsSEC FORM 4 Code J—1,033,912 at $0.00filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar Biosciencesoption or derivative · Life-science toolsSEC FORM 4 Code J—37,086 at $0.00filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar Biosciencesoption or derivative · Life-science toolsSEC FORM 4 Code J—37,086 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Qiming Corporate GP VI, Ltd.10% owner · 10% owner at Alamar Biosciences, filing Form 4 there in the last year
John L. BrottemGeneral Counsel · General Counsel at Alamar Biosciences, filing Form 4 there in the last year
Robert P. RagusaDirector · Director at Alamar Biosciences, filing Form 4 there in the last year
Justin J. McAnearChief Financial Officer · Chief Financial Officer at Alamar Biosciences, filing Form 4 there in the last year
Nicholas NaclerioDirector · Director at Alamar Biosciences, filing Form 4 there in the last year